Search Results - "DE LENA, M"

Leadership Styles in Agile Teams: An Analysis Based on Experience by Gutierrez, Gema, De Lena, M. Teresa Gonzalez, Garzas, Javier, Moguerza, Javier M.

“…This study covers the lack of literature analyzing the empirical relationship between leadership styles and self-management in agile frameworks. We have…”
Get full text

Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients by PARADISO, A, SIMONE, G, JOHNSTON, P. G, PETRONI, S, LEONE, B, VALLEJO, C, LACAVA, J, ROMERO, A, MACHIAVELLI, M, DE LENA, M, ALLEGRA, C. J

“…The purpose of this work was to analyse the ability of p53 and thymidilate synthase (TS) primary tumour expression to retrospectively predict clinical response…”
Get full text

Exploring the Effectiveness of OKRs in Enhancing Company Objectives: A Comparative Study by Criado, Juan M., Gutierrez, Gema, Garzas, Javier, Cano, Emilio L., de Lena, M. Teresa Gonzalez, Moguerza, Javier M.

“…The use of management by objectives (MBO) methodologies, particularly the Objectives and Key Results (OKR) framework, has gained widespread attention in recent…”
Get full text

Phase II trial of oral vinorelbine in combination with cisplatin followed by consolidation therapy with oral vinorelbine in advanced NSCLC by Lena, M. De, Ramlau, R., Hansen, O., Lorusso, V., Wagner, L., Barni, S., Cristovao, M.M., Huber, R., Alberola, V., Mitrovic, M., Colin, C., Gasmi, J.

“…Among the cytotoxic agents commonly combined with cisplatin in the treatment of advanced NSCLC, vinorelbine has led to significant outcome improvements. Adding…”
Get full text

Expression of apoptosis-related markers and clinical outcome in patients with advanced colorectal cancer by PARADISO, A, SIMONE, G, DE LENA, M, LEONE, B, VALLEJO, C, LACAVA, J, DELLAPASQUA, S, DAIDONE, M. G, COSTA, A

“…The clinical relevance of bax and bcl-2 protein expression has been investigated in 84 patients with recurrent or metastatic colorectal cancer submitted to a…”
Get full text

Hepatitis C virus infection in patients with B-cell lymphoproliferative disorders by GUIDA, M, D'ELIA, G, BENVESTITO, S, CASAMASSIMA, A, MICELLI, G, QUARANTA, M, MOSCHETTA, R, DE LENA, M, LORUSSO, V

“…Leukemia (2002) 16, 2162-2163. doi:10.1038/sj.leu.2402626…”
Get full text

A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum by Lorusso, V, Pollera, C.F, Antimi, M, Luporini, G, Gridelli, C, Frassineti, G.L, Oliva, C, Pacini, M, De Lena, M

“…The aim of this study was to evaluate the efficacy and safety of gemcitabine, a pyrimidine antimetabolite, in the treatment of advanced transitional cell…”
Get full text

Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study by De Lena, M., Lorusso, V., Latorre, A., Fanizza, G., Gargano, G., Caporusso, L., Guida, M., Catino, A., Crucitta, E., Sambiasi, D., Mazzei, A.

“…A potential way to improve the results obtained with the standard carboplatin/cisplatin (CDDP)-paclitaxel treatment regimen in advanced ovarian cancer is to…”
Get full text

Unusual Response to Second-Line Single-Agent Gemcitabine in Locally Advanced Primary Leiomyosarcoma of the Lung: A Case Report by Silvestris, N., Piscitelli, D., Crucitta, E., Fiore, MG, Lena, M. De, Lorusso, V.

“…Primary leiomyosarcomas (LMSs) of the lung are extremely rare malignancies that have been the subject of single or small series of case reports. Today, the…”
Get full text

Failure of primary breast cancer neoangiogenesis to predict pattern of distant metastasis by PARADISO, A, RANIERI, G, DE LENA, M, SILVESTRIS, N, NACCARATO, G, BEVILACQUA, G, MANGIA, A, LEONE, B, VALLEJO, C, SIMONE, G, SCHITTULLI, F

“…In the present study, the primary tumor neoangiogenesis characteristics of 81 stage IV previously untreated breast cancers with synchronous metastasis to…”
Get full text

High Efficacy of Paclitaxel and Doxorubicin as First-Line Therapy in Advanced Breast Cancer: A Phase I-II Study by Lena, M. De, Latorre, A., Calabrese, P., Catino, A., Lorusso, V., Mazzei, A., Aloe, A.

“…The aim of this study was to define the maximum tolerated dose (MTD) of paclitaxel (TAX) in combination with doxorubicin (ADM). To evaluate the efficacy and…”
Get full text

Carboplatin plus ifosfamide as salvage treatment of epithelial ovarian cancer: a pilot study by Lorusso, V, Catino, A, Leone, B, Rabinovich, M, Gargano, G, Paradiso, A, De Lena, M

“…This study aimed to evaluate the activity and toxicity of carboplatin (PPL) and ifosfamide (IFO) in patients with epithelial ovarian cancer previously treated…”
Get more information

Epithelial ovarian cancer: second and third line chemotherapy (review) by Latorre, A, De Lena, M, Catino, A, Crucitta, E, Sambiasi, D, Guida, M, Misino, A, Lorusso, V

“…Standard therapy for patients affected with advanced epithelial ovarian cancer is cytoreductive surgery followed by combination chemotherapy. With this…”
Get more information

Rationale for the use of gemcitabine in breast cancer (Review) by Silvestris, N, D'Aprile, M, Andreola, G, Locopo, N, Marini, L, Crucitta, E, De Lena, M, Lorusso, V

“…Many active cytotoxic drugs and several regimens exist for breast cancer therapy. However, these conventional treatments have not changed the outcome of…”
Get more information

Metastatic malignant melanoma of the gallbladder: a case report and review of the literature by Guida, M, Cramarossa, A, Gentile, A, Benvestito, S, De Fazio, M, Sanbiasi, D, Crucitta, E, De Lena, M

“…Both primary and metastatic melanoma of the gallbladder are rare. Involvement of the gallbladder occurs in about 15% of all gastrointestinal metastatic…”
Get full text

Randomized Clinical Trial of Adjuvant Fluorouracil, Epirubicin, and Cyclophosphamide Chemotherapy for Patients With Fast-Proliferating, Node-Negative Breast Cancer by PARADISO, Angelo, SCHITTULLI, Francesco, CELLAMARE, Giovanni, MANGIA, Annita, MARZULLO, Franco, LORUSSO, Vito, DE LENA, Mario

“…The prospective applicability of new biologic tumor information to personalize adjuvant treatment of women with operable breast cancer remains to be…”
Get full text

Phase I II study of gemcitabine plus mitoxantrone as salvage chemotherapy in metastatic breast cancer by LORUSSO, V, CRUCITTA, E, SCHITTULLI, F, CALABRESE, P, DE LENA, M, SILVESTRIS, N, CATINO, A, CAPORUSSO, L, MAZZEI, A, GUIDA, M, LATORRE, A, SAMBIASI, D, D'AMICO, C

“…The purpose of this study was to determine the maximum-tolerated dose of gemcitabine plus mitoxantrone in women with metastatic breast cancer (MBC) and to…”
Get full text

Phase I/II study of paclitaxel, gemcitabine and vinorelbine as first-line chemotherapy of non-small-cell lung cancer by Lorusso, V., Crucitta, E., Panza, N., Silvestris, N., Guida, M., Carpagnano, F., Mancarella, S., Sambiasi, D., De Lena, M.

“…Background: The aim of our study was to determine the maximum tolerated dose of paclitaxel combined with a fixed dose of gemcitabine and vinorelbine in the…”
Get full text

CEOP-B alternated with VIMB in intermediate-grade and high-grade non-Hodgkin's lymphoma: a pilot study by De Lena, M, Ditonno, P, Lorusso, V, Brandi, M, Timurian, A, Marzullo, F, Ventrella, V, Pellecchia, A

“…To improve response and toxicity in treatment of non-Hodgkin's lymphomas (NHLs), a prospective single-arm trial was initiated using cyclophosphamide,…”
Get more information

Metastatic pattern and DNA ploidy in stage IV breast cancer at initial diagnosis. Relation to response and survival by De Lena, M, Romero, A, Rabinovich, M, Leone, B, Vallejo, C, Machiavelli, M, Cuevas, M, Rodriguez, R, Lacava, J, Perez, J

“…Sixty-nine patients with metastatic breast cancer (MBC) at initial diagnosis were analyzed to verify if metastatic pattern and clinical outcome are related to…”
Get more information